Duncan Jarvis

I'm Multimedia Editor here at the BMJ.

It's, yeah, from being horizontal so much at home.

So, as I said, last week we talked about pneumonia a little bit.

And Carl, it seems like NICE have paid attention to what you were saying.

And we'll do that so everyone can access that.

Great.

So as always, every week we try and do a start and a stop and continuing that in this new coronavirus world.

So the question I've been wondering about is,

chloroquine or hydroxychloroquine.

We've seen Trump really pushing this and that's led to some problems.

India, which is one of the large producers, first stopped export and now they've allowed that to happen again.

But just seems like there is a lot happening around this drug and lots of uncertain evidence.

Helen, you've been having a look at this.

Now, talking about evidence, online on the BMJ, we have just published another systematic review, this time looking at diagnostic and prognostic models, and they very much have found the same thing.

Helen, you spoke to them about this, the sort of evidence that they've managed to find.

So another thing that's been rumbling on and you might have if you've looked at the BMJ social media scene calls for proper PPE.

It's actually defining what proper PPE is and that's where we should be looking at the evidence.

Now, Helen, you've put face masks on the agenda for this week.

Why did you choose face masks over all the other kind of PPE?

Have you got some new evidence?